Work

A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin ineligible muscle invasive bladder cancer

Year: 2024

Type: article

Source: European Urology

DOI: 10.1016/s0302-2838(24)00376-2

Authors: R. Satkunasivam, B.S. Teh, C. Riveros, K. Lim, C.J.D. Wallis, S. Hu, Z. Melchiode, F. Nikolos, B.J. Miles, D. Kaushik, S.H. Chen, E. Efstathiou, K.S. Chan, N.F. Esnaola, G.P. Sonpavde

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4392765249

FWCI:

Cites:

Cited by:

Related to: 10